The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 20, 2021
Filed:
Mar. 20, 2018
Applicants:
Novartis Ag, Basel, CH;
Beth Israel Deaconess Medical Center, Inc., Boston, MA (US);
Inventors:
Anthony Rosenzweig, Newton, MA (US);
Jason D. Roh, Brookline, MA (US);
David J. Glass, Cambridge, MA (US);
Assignees:
Novartis AG, Basel, CH;
Beth Israel Deaconess Medical Center, Inc., Boston, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61P 9/04 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2863 (2013.01); A61P 9/04 (2018.01); C07K 2317/76 (2013.01);
Abstract
The disclosure relates to novel uses and methods for preventing and/or treating heart disease, which employ a therapeutically effective amount of an ActRII receptor antagonist, e.g., an ActRII receptor binding molecule, e.g., an ActRII receptor antibody, such as the bimagrumab antibody.
Quick Actions:
Rosenzweig, Anthony. (2021). Methods for treating and/or reducing the likelihood of heart failure by administering anti-activin receptor type ii (anti-actrii) antibody (U.S. Patent No. 10982000). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10982000
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile